Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: NOD-like receptor signaling pathway (mmu04621)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Birc1f
KLA  ATP  ATP+KLA
 NM_010871 baculoviral IAP repeat-containing 1f (Birc1f), mRNA [NM_010871] KLA 1.23 1.26 1.49 1.28 1.40 1.41 1.45
ATP 1.18 1.18 1.05 1.15 .78 .76 1.02
KLA/ATP 1.49 1.45 1.18 1.27 .75 .94 1.14
Birc2
KLA  ATP  ATP+KLA
 NM_007465 baculoviral IAP repeat-containing 2 (Birc2), mRNA [NM_007465] KLA 4.63 4.59 3.77 2.79 2.32 2.07 1.84
ATP .95 .88 .84 .92 .76 1.34 1.28
KLA/ATP 4.70 4.93 4.13 2.60 1.34 1.60 2.31
Birc3
KLA  ATP  ATP+KLA
 BC011338 baculoviral IAP repeat-containing 3, mRNA (cDNA clone MGC:18386 IMAGE:3661563), complete cds [BC011338] KLA 5.48 5.46 4.94 4.16 4.91 3.36 3.74
ATP 1.05 1.08 4.21 4.28 2.59 2.55 1.57
KLA/ATP 6.78 8.91 11.01 4.87 2.28 2.12 3.66
Birc3
KLA  ATP  ATP+KLA
 NM_007464 baculoviral IAP repeat-containing 3 (Birc3), mRNA [NM_007464] KLA 17.83 15.88 13.48 11.14 11.79 6.90 6.10
ATP 1.14 1.16 1.70 4.07 5.00 6.33 2.41
KLA/ATP 14.77 16.44 19.09 13.91 8.27 6.22 7.73
Card6
KLA  ATP  ATP+KLA
 XM_139295 gb|PREDICTED: Mus musculus caspase recruitment domain family, member 6 (Card6), mRNA [XM_139295] KLA 1.46 1.39 1.48 1.24 1.22 1.95 1.61
ATP 1.00 .92 .95 .53 .38 1.05 1.46
KLA/ATP 1.50 1.35 1.47 .82 .65 1.38 2.33
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Ccl12
KLA  ATP  ATP+KLA
 NM_011331 chemokine (C-C motif) ligand 12 (Ccl12), mRNA [NM_011331] KLA 40.77 33.71 46.23 51.22 57.13 57.92 16.26
ATP 1.41 1.14 1.54 1.79 1.41 1.89 9.34
KLA/ATP 39.52 43.18 61.96 69.72 62.95 38.70 29.25
Ccl2
KLA  ATP  ATP+KLA
 NM_011333 chemokine (C-C motif) ligand 2 (Ccl2), mRNA [NM_011333] KLA 10.26 9.30 8.35 10.02 8.92 14.08 11.59
ATP 1.62 1.68 2.20 4.16 3.92 4.84 17.45
KLA/ATP 10.09 10.31 10.95 12.32 8.00 10.04 21.29
Ccl5
KLA  ATP  ATP+KLA
 M77747 rantes mRNA, complete cds. [M77747] KLA 63.18 60.41 56.25 63.63 58.00 66.51 67.20
ATP .91 1.08 1.25 1.90 4.34 16.10 26.07
KLA/ATP 55.92 63.34 72.91 65.68 70.81 71.97 81.34
Ccl5
KLA  ATP  ATP+KLA
 NM_013653 chemokine (C-C motif) ligand 5 (Ccl5), mRNA [NM_013653] KLA 40.31 35.22 27.92 38.59 29.29 37.98 28.83
ATP .86 .92 1.43 1.66 3.86 15.09 16.66
KLA/ATP 32.14 31.72 47.19 35.89 42.00 46.15 43.89
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Cxcl1
KLA  ATP  ATP+KLA
 NM_008176 chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176] KLA 36.87 30.25 15.74 8.84 5.41 3.01 5.84
ATP 2.77 8.26 128.38 289.44 262.38 218.83 26.91
KLA/ATP 41.06 56.76 91.82 164.83 91.44 77.89 79.05
Cxcl2
KLA  ATP  ATP+KLA
 NM_009140 chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140] KLA 20.11 17.63 13.50 7.78 9.14 3.98 10.85
ATP 10.96 27.84 145.37 396.18 303.88 165.35 21.04
KLA/ATP 33.28 74.00 189.99 348.56 93.84 68.75 64.87
Erbb2ip
KLA  ATP  ATP+KLA
 AK046880 10 days neonate medulla oblongata cDNA, RIKEN full-length enriched library, clone:B830047G01 product:Erbb2 interacting protein, full insert sequence. [AK046880] KLA 1.05 .85 .92 .92 1.48 1.37 .90
ATP .84 .71 1.01 1.70 1.27 1.48 1.06
KLA/ATP .86 .77 1.27 1.15 1.30 .96 1.20
Erbb2ip
KLA  ATP  ATP+KLA
 NM_001005868 Erbb2 interacting protein (Erbb2ip), transcript variant 1, mRNA [NM_001005868] KLA 1.58 1.58 1.46 1.30 1.46 1.32 1.19
ATP 1.13 1.20 .92 1.36 1.43 1.04 1.17
KLA/ATP 1.67 1.81 1.17 1.50 .98 .82 1.28
Hsp90aa1
KLA  ATP  ATP+KLA
 NM_010480 heat shock protein 90, alpha (cytosolic), class A member 1 (Hsp90aa1), mRNA [NM_010480] KLA .95 1.03 .90 .92 .80 .94 .99
ATP .96 .92 1.39 1.21 2.02 3.66 1.10
KLA/ATP .93 .92 1.32 1.01 1.85 2.21 1.20
Hsp90ab1
KLA  ATP  ATP+KLA
 NM_008302 heat shock protein 90kDa alpha (cytosolic), class B member 1 (Hsp90ab1), mRNA [NM_008302] KLA .93 1.02 .98 .82 .95 1.10 1.39
ATP 1.04 1.14 .92 1.32 1.19 1.02 .63
KLA/ATP 1.02 1.04 .80 1.12 .87 .86 .75
Hsp90b1
KLA  ATP  ATP+KLA
 NM_011631 heat shock protein 90, beta (Grp94), member 1 (Hsp90b1), mRNA [NM_011631] KLA .78 .83 .71 .69 .73 .69 .80
ATP 1.00 1.08 1.01 .94 .84 .84 .66
KLA/ATP .78 .82 .81 .73 .66 .68 .27
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Map3k7ip
1
KLA  ATP  ATP+KLA
 NM_025609 mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (Map3k7ip1), mRNA [NM_025609] KLA .32 .30 .35 .56 .67 .82 .76
ATP .95 .81 .80 .42 .35 .40 .80
KLA/ATP .33 .30 .37 .20 .45 .62 .65
Map3k7ip
2
KLA  ATP  ATP+KLA
 AK086230 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930015C19 product:inferred: Mus musculus, Similar to TAK1-binding protein 2; KIAA0733 protein, clone MGC:8010 IMAGE:3586132, mRNA, complete cds, full insert sequence. [A KLA 1.14 1.02 1.07 1.03 1.13 1.02 .96
ATP 1.00 .88 .92 .90 1.06 .96 .94
KLA/ATP 1.05 1.00 .90 .98 1.02 .97 .97
Map3k7ip
2
KLA  ATP  ATP+KLA
 NM_138667 mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (Map3k7ip2), mRNA [NM_138667] KLA 3.43 3.22 3.19 2.41 2.13 1.51 1.10
ATP 1.08 1.08 .86 .81 1.30 1.32 1.02
KLA/ATP 3.34 3.66 3.00 2.58 1.80 1.52 1.61
Map3k7ip
3
KLA  ATP  ATP+KLA
 NM_025729 mitogen-activated protein kinase kinase kinase 7 interacting protein 3 (Map3k7ip3), mRNA [NM_025729] KLA 1.21 1.05 1.20 1.24 1.12 1.26 1.18
ATP 1.02 .88 1.07 .64 1.38 1.88 .95
KLA/ATP 1.13 1.11 1.21 .75 1.58 1.74 1.38
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mefv
KLA  ATP  ATP+KLA
 NM_019453 Mediterranean fever (Mefv), mRNA [NM_019453] KLA 10.17 8.71 13.00 25.13 28.38 18.72 23.68
ATP 1.14 .91 1.56 1.91 8.11 34.39 13.16
KLA/ATP 8.45 9.10 14.18 9.17 14.01 47.15 60.56
Mm.14371
8
KLA  ATP  ATP+KLA
 9506892 Unknown KLA 10.27 9.94 12.90 21.81 28.02 20.29 25.43
ATP .94 .86 1.53 1.90 7.47 36.47 15.04
KLA/ATP 7.93 8.82 13.64 10.30 13.65 47.70 72.05
Mm.22263
3
KLA  ATP  ATP+KLA
 83977453 Unknown KLA 16.47 14.58 14.05 17.89 13.04 11.85 6.01
ATP 1.14 .97 1.34 1.39 4.26 11.88 2.10
KLA/ATP 16.16 16.61 15.95 7.90 9.42 13.83 13.56
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.31188
4
KLA  ATP  ATP+KLA
 146198620 Unknown KLA .69 .70 .77 1.02 1.29 2.04 1.80
ATP .91 .82 .91 .83 1.09 2.72 1.14
KLA/ATP .65 .57 .81 .73 .88 2.07 3.86
Mm.33565
9
KLA  ATP  ATP+KLA
 160333365 Unknown KLA 5.54 4.69 3.93 3.03 2.00 1.91 1.69
ATP .98 .81 1.01 .78 .68 1.71 1.10
KLA/ATP 5.05 4.44 5.07 2.38 1.34 1.88 2.00
Mm.34073
8
KLA  ATP  ATP+KLA
 51921280 Unknown KLA 1.01 1.04 .82 1.06 1.02 1.05 .99
ATP 1.00 1.01 1.01 .97 .96 1.02 1.06
KLA/ATP .95 1.01 1.01 1.01 .99 1.00 1.01
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.6898
KLA  ATP  ATP+KLA
 114431261 Unknown KLA 1.64 1.74 1.72 2.04 2.10 3.30 4.37
ATP .91 .89 1.30 1.30 1.20 1.74 2.92
KLA/ATP 1.55 1.79 2.35 1.74 2.10 4.16 7.14
Naip1
KLA  ATP  ATP+KLA
 NM_008670 NLR family, apoptosis inhibitory protein 1 (Naip1), mRNA [NM_008670] KLA .99 .97 1.00 .97 .95 1.23 2.04
ATP 1.01 1.01 .99 1.10 .96 1.05 1.13
KLA/ATP 1.00 .99 1.00 .96 .99 1.51 2.34
Naip2
KLA  ATP  ATP+KLA
 NM_010872 NLR family, apoptosis inhibitory protein 2 (Naip2), transcript variant 1, mRNA [NM_010872] KLA 1.34 1.30 1.51 1.87 2.03 2.04 2.38
ATP 1.23 1.14 1.07 .78 1.36 4.78 1.82
KLA/ATP 1.53 1.56 1.46 1.11 1.50 4.78 5.42
Naip5
KLA  ATP  ATP+KLA
 NM_010870 NLR family, apoptosis inhibitory protein 5 (Naip5), mRNA [NM_010870] KLA 1.26 1.22 1.40 1.37 1.81 2.01 1.38
ATP 1.00 .96 1.17 1.14 .84 1.12 .95
KLA/ATP 1.27 1.29 1.57 1.38 1.60 2.00 1.76
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Nlrc4
KLA  ATP  ATP+KLA
 NM_001033367 NLR family, CARD domain containing 4 (Nlrc4), mRNA [NM_001033367] KLA .81 .77 .85 .98 1.35 1.96 1.86
ATP 1.09 .92 .83 .90 1.19 1.63 1.12
KLA/ATP .83 .72 .90 .94 .92 1.64 3.46
Nlrp1a
KLA  ATP  ATP+KLA
 NM_001004142 NLR family, pyrin domain containing 1A (Nlrp1a), mRNA [NM_001004142] KLA .93 .95 .90 .93 .98 1.06 1.20
ATP 1.09 1.23 1.02 1.07 .77 .71 1.09
KLA/ATP 1.03 .97 .80 .93 .78 .68 1.01
Nlrp3
KLA  ATP  ATP+KLA
 NM_145827 NLR family, pyrin domain containing 3 (Nlrp3), mRNA [NM_145827] KLA 4.67 4.59 4.29 3.00 4.04 2.15 1.70
ATP 1.00 1.06 1.26 4.90 5.57 4.69 .69
KLA/ATP 4.03 4.02 2.51 5.32 2.64 4.12 2.61
Nod1
KLA  ATP  ATP+KLA
 NM_172729 nucleotide-binding oligomerization domain containing 1 (Nod1), mRNA [NM_172729] KLA 25.78 23.94 24.21 25.85 17.65 20.45 9.89
ATP .87 .76 1.03 .75 1.29 5.39 1.51
KLA/ATP 22.46 23.31 35.45 21.24 15.96 16.02 13.86
Nod2
KLA  ATP  ATP+KLA
 NM_145857 nucleotide-binding oligomerization domain containing 2 (Nod2), mRNA [NM_145857] KLA 12.51 10.83 11.39 11.89 10.66 9.06 5.17
ATP 1.27 1.10 1.30 1.48 4.63 8.23 2.33
KLA/ATP 12.86 12.85 13.93 8.85 9.30 10.43 11.67
Pstpip1
KLA  ATP  ATP+KLA
 NM_011193 proline-serine-threonine phosphatase-interacting protein 1 (Pstpip1), mRNA [NM_011193] KLA .96 .99 1.11 1.30 1.69 1.97 1.67
ATP .96 .92 .62 .68 1.11 1.23 1.51
KLA/ATP 1.01 .92 .69 .70 .93 1.32 2.25
Pycard
KLA  ATP  ATP+KLA
 NM_023258 PYD and CARD domain containing (Pycard), mRNA [NM_023258] KLA 1.48 1.44 1.62 1.81 1.80 1.69 .94
ATP .89 .88 1.00 .84 .52 .30 .62
KLA/ATP 1.32 1.34 1.65 1.38 1.14 .50 .41
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Ripk2
KLA  ATP  ATP+KLA
 NM_138952 receptor (TNFRSF)-interacting serine-threonine kinase 2 (Ripk2), mRNA [NM_138952] KLA 19.51 18.67 18.82 10.27 5.08 3.42 2.58
ATP 1.05 1.02 1.41 3.66 9.06 6.82 1.68
KLA/ATP 19.33 20.48 15.93 16.05 8.62 9.36 5.23
Sugt1
KLA  ATP  ATP+KLA
 AK141416 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530010F03 product:SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae), full insert sequence [AK141416] KLA 1.03 1.08 1.12 1.02 1.00 .88 .59
ATP 1.01 1.03 1.03 1.03 .98 .60 .31
KLA/ATP 1.15 1.08 1.01 1.00 .92 .69 .27
Sugt1
KLA  ATP  ATP+KLA
 NM_026474 SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) (Sugt1), mRNA [NM_026474] KLA 1.29 1.36 1.23 1.32 1.21 1.35 1.02
ATP .94 .86 1.13 .99 1.10 1.58 1.14
KLA/ATP 1.21 1.26 1.52 1.33 1.55 1.52 1.50
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfaip3
KLA  ATP  ATP+KLA
 NM_009397 tumor necrosis factor, alpha-induced protein 3 (Tnfaip3), mRNA [NM_009397] KLA 29.69 27.73 21.42 18.86 14.42 8.13 7.48
ATP 1.73 4.86 21.57 43.06 30.03 18.86 8.31
KLA/ATP 29.39 35.88 40.64 52.71 33.19 25.38 17.75
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trip6
KLA  ATP  ATP+KLA
 NM_011639 thyroid hormone receptor interactor 6 (Trip6), mRNA [NM_011639] KLA 1.69 1.85 1.55 1.57 1.72 1.62 .97
ATP 1.01 1.06 1.10 1.30 1.36 1.15 .93
KLA/ATP 1.87 1.76 1.84 1.69 1.93 1.31 .96